Build-up strategies are a powerful way to accelerate growth, expand capabilities, and scale rapidly across Life Sciences and Healthcare. Acquisitions can enable entry into new geographies, expansion of service offerings, portfolio diversification, or consolidation of fragmented markets. Without a structured approach, however, build-ups can destroy value through overpayment, poor integration, or lack of strategic coherence.
We help investors and corporates design and execute disciplined build-up strategies grounded in clear strategic logic. Our work includes search & screen activities, target prioritization, and evaluation of strategic, commercial, and operational fit. We assess opportunities across products, services, and care models — including pharma services (CROs, CDMOs, testing platforms), Consumer Health, and healthcare services such as pharmacy networks or care providers.Our analyses go beyond individual targets to assess platform scalability, synergy potential, integration complexity, and repeatability of the acquisition thesis. We support clients in defining acquisition roadmaps, prioritizing targets, and preparing post-deal integration and governance models. By combining strategic clarity with rigorous screening and execution support, we help clients use build-ups as a deliberate and effective growth engine.
